UY33665A - Derivado peptídico - Google Patents

Derivado peptídico

Info

Publication number
UY33665A
UY33665A UY0001033665A UY33665A UY33665A UY 33665 A UY33665 A UY 33665A UY 0001033665 A UY0001033665 A UY 0001033665A UY 33665 A UY33665 A UY 33665A UY 33665 A UY33665 A UY 33665A
Authority
UY
Uruguay
Prior art keywords
arg
nal
asn
tyr
leu
Prior art date
Application number
UY0001033665A
Other languages
English (en)
Inventor
Asami Taiji
Nishizawa Naoki
Kanematsu Yoko
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY33665A publication Critical patent/UY33665A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

La presente invención se refiere a un derivado peptídico seleccionado del grupo que consiste en PEG 20k(AL)-ß-Ala-Tyr-Nal(1)-Leu-Phe-Arg-Pro-Arg-Asn-NH2, PEG20k(AL)-ß-Ala-Tyr-Nal(2)-Leu-Phe-Arg-Pro-Arg-Asn-NH2, PEG20k(AL)-NpipAc-Tyr-Nal(2)-Leu-Phe-Arg-Pro-Arg-Asn-NH2, PEG20k(AL)-NpipAc-Tyr-Nal(2)-Leu-Phe-Arg-Ala-Arg-Asn-NH2, PEG20k(AL)-PEG(2)-Tyr-Nal(2)-Leu-Phe-Arg-NMeAla-Arg-Asn-NH2, PEG20k(AL)-Pic(4)-Tyr-Nal(2)-Leu-Phe-Arg-NMeAla-Arg-Asn-NH2, PEG20k(AL)-Acp-Tyr-Nal(2)-Leu-Phe-Arg-NMeAla-Arg-Asn-NH2,and PEG20k(AL)-ß-Ala-Tyr-Nal(2)-Leu-P ya(4)-Arg-Pro-Arg-Asn-NH2; o una sal de los anteriores.
UY0001033665A 2010-10-13 2011-10-12 Derivado peptídico UY33665A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010231016A JP2013209295A (ja) 2010-10-13 2010-10-13 ペプチド誘導体

Publications (1)

Publication Number Publication Date
UY33665A true UY33665A (es) 2012-05-31

Family

ID=44906303

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001033665A UY33665A (es) 2010-10-13 2011-10-12 Derivado peptídico

Country Status (6)

Country Link
US (1) US20120094898A1 (es)
JP (1) JP2013209295A (es)
AR (1) AR083395A1 (es)
TW (1) TW201305219A (es)
UY (1) UY33665A (es)
WO (1) WO2012050227A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8752157B2 (en) 2011-08-15 2014-06-10 Bank Of America Corporation Method and apparatus for third party session validation
US8752123B2 (en) 2011-08-15 2014-06-10 Bank Of America Corporation Apparatus and method for performing data tokenization
US8726340B2 (en) 2011-08-15 2014-05-13 Bank Of America Corporation Apparatus and method for expert decisioning
US9361443B2 (en) 2011-08-15 2016-06-07 Bank Of America Corporation Method and apparatus for token-based combining of authentication methods
US9253197B2 (en) 2011-08-15 2016-02-02 Bank Of America Corporation Method and apparatus for token-based real-time risk updating
US8572686B2 (en) 2011-08-15 2013-10-29 Bank Of America Corporation Method and apparatus for object transaction session validation
US8850515B2 (en) 2011-08-15 2014-09-30 Bank Of America Corporation Method and apparatus for subject recognition session validation
US8572724B2 (en) 2011-08-15 2013-10-29 Bank Of America Corporation Method and apparatus for network session validation
US8572687B2 (en) 2011-08-15 2013-10-29 Bank Of America Corporation Apparatus and method for performing session validation
US8458781B2 (en) 2011-08-15 2013-06-04 Bank Of America Corporation Method and apparatus for token-based attribute aggregation
US9159065B2 (en) 2011-08-15 2015-10-13 Bank Of America Corporation Method and apparatus for object security session validation
GB201315335D0 (en) * 2013-08-29 2013-10-09 Of Singapore Amino diacids containing peptide modifiers
US10457629B2 (en) 2013-08-30 2019-10-29 Yale University Therapeutic DNP derivatives and methods using same
JP6706204B2 (ja) 2013-08-30 2020-06-03 イエール ユニバーシティ 新規２，４−ジニトロフェノール製剤およびその使用法
EP2842965A1 (en) 2013-09-03 2015-03-04 Gubra ApS Neuromedin U analogs comprising serum albumin binding amino acid residue
EP3554516A1 (en) 2016-12-13 2019-10-23 Limm Therapeutics, SA Methods of treating diseases associated with ilc2 cells

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997010224A1 (en) 1995-09-13 1997-03-20 Takeda Chemical Industries, Ltd. Benzoxazepine compounds, their production and use as lipid lowering agents
AR035016A1 (es) 1999-08-25 2004-04-14 Takeda Chemical Industries Ltd Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
JP2002265497A (ja) * 2001-03-12 2002-09-18 Tadashi Hashimoto 生理活性ペプチドニューロメジンｕの高活性誘導体
AU2006329836A1 (en) 2005-12-16 2007-07-05 Amylin Pharmaceuticals, Llc Compositions and methods for treating obesity and related metabolic disorders
RU2008141280A (ru) 2006-03-20 2010-04-27 Мерк энд Ко., Инк. (US) Агонисты рецептора нейромедина u и их применение
WO2009042053A2 (en) 2007-09-21 2009-04-02 Merck & Co., Inc. Neuromedin u receptor agonists and uses thereof
CA2701612A1 (en) 2007-10-05 2009-04-09 Takeda Pharmaceutical Company Limited Neuromedin u derivative
US20100106795A1 (en) 2008-10-29 2010-04-29 Motorol, Inc. Variable size message indicator in communication device
CA2741991A1 (en) 2008-11-05 2010-05-14 Merck Sharp & Dohme Corp. Mechanism of neuromedin u action and uses thereof
ES2525179T3 (es) 2009-04-08 2014-12-18 Takeda Pharmaceutical Company Limited Derivado de neuromedina U
WO2010138343A1 (en) 2009-05-27 2010-12-02 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof

Also Published As

Publication number Publication date
US20120094898A1 (en) 2012-04-19
TW201305219A (zh) 2013-02-01
JP2013209295A (ja) 2013-10-10
AR083395A1 (es) 2013-02-21
WO2012050227A1 (en) 2012-04-19

Similar Documents

Publication Publication Date Title
UY33665A (es) Derivado peptídico
UY39128A (es) Composiciones y métodos para modular la senda de señalización de wnt
CO2018006299A2 (es) Compuestos novedosos
AR080301A1 (es) Anticuerpos e inmunoconjugados del receptor 1 de folato y sus usos
EA201391602A1 (ru) Контролируемое высвобождение иммунодепрессантов из синтетических наноносителей
CY1117650T1 (el) Νεες ανοσοενισχυτικες συνθεσεις
CY1121742T1 (el) Αντισωματα s100a4 και θεραπευτικες χρησεις αυτων
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
CY1121560T1 (el) Ανοσογονικη συνθεση
CR20140143A (es) 3-pirmidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante
MA39362A1 (fr) Compositions stables d'iode non complexé et procédés d'utilisation.
EA201171478A1 (ru) Наноносители, имеющие компоненты с различными скоростями высвобождения
BR112014019171A8 (pt) Composições intranasais de dexdetomida e seus métodos de uso
EA201590887A1 (ru) Композиция
CR20120018A (es) Profármacos que comprenden un conjugado de insulina-conector
EA201590173A1 (ru) Иммуноконъюгаты, содержащие антитела к cd22
ECSP14013179A (es) Compuesto inhibidor de la señalización de la trayectoria notch
AR112787A2 (es) Compuestos 1,5-difenil-penta-1,4-dien-3-ona
BR112014013108A2 (pt) compostos tricíclicos fundidos como inibidores da quinase raf
NI201200168A (es) Formulaciones farmacéuticas
EA201390613A1 (ru) Обогащенный дейтерием расагилин
AR088297A1 (es) R(+)-n-formil-propargil-aminoindano
EA201600442A1 (ru) Мягкая фармацевтическая композиция на водной основе, содержащая тапентадол
CR20110706A (es) Composición higienizante
CY1117912T1 (el) Ενωσεις πυραζολιου ως αναστολεiς του συμμεταφορεα νατριου-γλυκοζης 1 (sglt1)